Skip to main content
OpenTrials
Completed

NCT Number: NCT02176850

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

This post-marketing surveillance study was designed to supplement under conditions of normal clinical practice the data on the safety, tolerability and efficacy of Micardis® collected during the clinical studies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of both sexes with essential hypertension and a minimum age of 18 years

Exclusion criteria

(Not applicable)

Treatment and study plan

Micardis®

Drug

Primary outcomes

  1. Indicence of ulcera

    Time frame: Up to 6 months after start of study

  2. Incidence of gastrointestinal (GI) bleedings

    Time frame: Up to 6 months after start of study

Secondary outcomes

  1. Incidence of adverse events (GI-complaints inclusive)

    Time frame: Up to 6 months after start of study

  2. Change from baseline in office blood pressure

    Time frame: Up to 6 months after start of study

  3. Response rate

    Time frame: Up to 6 months after start of study

    full response: reduction of diastolic blood pressure (DBP) by >= 10 mmHg or final DBP <= 90 mmHg overall response: reduction of DBP by >= 7mmHg or final DBP <= 90 mmHg

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Safety, Tolerability and Efficacy of Micardis® (Telmisartan) in Patients With Essential Hypertension

Important dates

Study start
1999
Primary completion
2000
First posted
Jun 27, 2014
Registry last updated
Jul 8, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.